These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 7681287

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Immunoactive effects of various mistletoe lectin-1 dosages in mammary carcinoma patients].
    Beuth J, Stoffel B, Ko HL, Buss G, Tunggal L, Pulverer G.
    Arzneimittelforschung; 1995 Apr; 45(4):505-7. PubMed ID: 7779151
    [Abstract] [Full Text] [Related]

  • 3. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.
    Heiny BM, Beuth J.
    Anticancer Res; 1994 Apr; 14(3B):1339-42. PubMed ID: 8067703
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Correlation of immune cell activities and beta-endorphin release in breast carcinoma patients treated with galactose-specific lectin standardized mistletoe extract.
    Heiny BM, Albrecht V, Beuth J.
    Anticancer Res; 1998 Apr; 18(1B):583-6. PubMed ID: 9568181
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thymocyte proliferation and maturation in response to galactoside-specific mistletoe lectin-1.
    Beuth J, Ko HL, Tunggal L, Steuer MK, Geisel J, Jeljaszewicz J, Pulverer G.
    In Vivo; 1993 Apr; 7(5):407-10. PubMed ID: 8110981
    [Abstract] [Full Text] [Related]

  • 8. [Immunoactive action of mistletoe lectin-1 in relation to dose].
    Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G.
    Arzneimittelforschung; 1994 Nov; 44(11):1255-8. PubMed ID: 7848341
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.
    Hajto T, Hostanska K, Gabius HJ.
    Cancer Res; 1989 Sep 01; 49(17):4803-8. PubMed ID: 2758413
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract.
    Stein GM, Berg PA.
    Eur J Med Res; 1998 Jun 17; 3(6):307-14. PubMed ID: 9620894
    [Abstract] [Full Text] [Related]

  • 17. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
    Galanina OE, Kaltner H, Khraltsova LS, Bovin NV, Gabius HJ.
    J Mol Recognit; 1997 Jun 17; 10(3):139-47. PubMed ID: 9408830
    [Abstract] [Full Text] [Related]

  • 18. Influence of treatment with the immunomodulatory effective dose of the beta-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental model systems.
    Beuth J, Ko HL, Gabius HJ, Pulverer G.
    In Vivo; 1991 Jun 17; 5(1):29-32. PubMed ID: 1932621
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.